Dynamic Imaging of EMT in the Breast Cancer Microenvironment
乳腺癌微环境中EMT的动态成像
基本信息
- 批准号:8843268
- 负责人:
- 金额:$ 63.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-05 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAlternative SplicingAnimal ModelAnimalsArchitectureBackBiological ModelsBlood CirculationBreastBreast Cancer CellBreast CarcinomaBreast Epithelial CellsBreast cancer metastasisCaliberCellsComplexConfocal MicroscopyCoupledCuesCytometryDevelopmentDevelopmental ProcessDevicesDisease ProgressionDistantDrug resistanceEarEngineeringEpithelial CellsEventExonsFatty acid glycerol estersGenesGoalsGrantHumanImageImplantIndividualInterventionLabelLeadLengthLifeMammary Gland ParenchymaMammary glandMeasuresMesenchymalMethodsMicroscopeMicroscopicMiniaturizationModelingMolecularMolecular TargetMonitorMusNeoplasm Circulating CellsNeoplasm MetastasisOptical reporterOpticsOrganPatternPerformancePhenotypePopulationPrimary NeoplasmProcessRNA SplicingRattusReporterReportingResistanceResolutionRodent ModelScanningSideSignal TransductionSiteTestingTherapeutic InterventionTimeTissuesTumor Cell InvasionTumor-Associated VasculatureWorkbasecancer cellcell motilitydesignepithelial to mesenchymal transitionfluorescence microscopeimplantable deviceimplantationin vivoin vivo imagingintravital imagingmalignant breast neoplasmmetastatic processmigrationminiaturizemolecular imagingmortalitymouse modelneoplastic cellnext generationnovelprotein expressionpublic health relevanceresponsesealtherapy resistanttissue culturetissue phantomtooltumortumor microenvironment
项目摘要
DESCRIPTION (provided by applicant): Metastasis and resistance to therapy are the most deadly aspects of breast cancer, and yet the conditions within the tumor microenvironment that lead to cancer cell dissemination and resistance are not fully understood. The molecular events that initiate and sustain these processes occur as rare events in the tumor microenvionment and revealing these early, subtle changes in the microenvironment will require high resolution, multiparametric in vivo microscopic approaches and reporter constructs that can characterize dynamic cellular events that lead to invasion, intravasation, and colonization of distant tissues. We will monitor breast cancer cells harboring optical reporters that signal key molecular events associated with the metastatic process in culture and in two animal models using a miniature dual-axis confocal (DAC) fluorescent microscope. This multispectral microscope is capable of detecting multiple markers of disease progression, and its novel architecture has enabled radical miniaturization conducive to implantation in rodent models for continuous study of the microenvironment. Although the applications for these devices for in vivo imaging are broad, we focus here on monitoring the critical steps of epithelial to mesenchymal transition (EMT) and back-MET. EMT is a developmental process in which organized epithelial cells transition into isolated, migratory cells with mesenchymal phenotypes, and underlies key steps in the metastatic process. We have identified a novel set of alternative splicing events associated specifically with breast cancer cell EMT and MET. We propose to engineer breast epithelial cells to report these events by transducing them with switchable bichromatic fluorescent reporters that indicate EMT status based on splicing patterns. As these reporter cells initiate EMT or MET, the coupled splicing events will result in a change in fluorescent protein expression, allowing our
miniature confocal microscopes to assess cellular status within the microenvironment. We will test the hypothesis that EMT splicing events associate with, and report, key early steps leading to invasion and intravasation within the breast cancer microenvironment in three aims: 1) engineer breast tumor cells to report EMT/MET-associated alternative splicing events, 2) monitor and validate EMT/MET reporter expression in labeled breast cancer cells within human breast tissue explant and ectopic mouse model systems using an existing handheld DAC microscope, and 3) adapt the DAC microscope as an implantable device to evaluate EMT/MET-associated splicing events in the tumor microenvironment of an orthotopic rat mammary carcinoma model. This work will result in the development of implantable microscopes for serial, high resolution, multiparametric imaging, and switchable molecular reporters that reveal dynamic processes within the tumor microenvironment of living animal models.
描述(由申请人提供):转移和对治疗的抵抗是乳腺癌最致命的方面,然而肿瘤微环境中导致癌细胞传播和抵抗的条件尚不完全清楚。启动和维持这些过程的分子事件在肿瘤微环境中是罕见的事件,揭示微环境中这些早期微妙的变化将需要高分辨率、多参数的体内显微镜方法和报告构建,这些方法可以表征导致远处组织入侵、内渗和定植的动态细胞事件。我们将使用微型双轴共聚焦(DAC)荧光显微镜,在培养和两种动物模型中监测携带与转移过程相关的关键分子事件信号的乳腺癌细胞。这种多光谱显微镜能够检测疾病进展的多种标志物,其新颖的结构使其能够彻底小型化,有利于植入啮齿动物模型,以便连续研究微环境。尽管这些设备在体内成像的应用范围很广,但我们在这里关注的是监测上皮细胞向间质转化(EMT)和back-MET的关键步骤。EMT是一个发育过程,在这个过程中,有组织的上皮细胞转变为分离的、具有间充质表型的迁移细胞,是转移过程的关键步骤。我们已经确定了一组新的与乳腺癌细胞EMT和MET特异性相关的选择性剪接事件。我们建议通过使用可切换的双色荧光报告器(基于剪接模式指示EMT状态)来转导乳腺上皮细胞来报告这些事件。当这些报告细胞启动EMT或MET时,偶联剪接事件将导致荧光蛋白表达的变化,从而使我们的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER H CONTAG其他文献
CHRISTOPHER H CONTAG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER H CONTAG', 18)}}的其他基金
9th Annual Meeting of the World Molecular Imaging Society - World Molecular Imaging Congress: "Imaging Biology... Improving Therapy"
世界分子影像学会第九届年会——世界分子影像大会:“影像生物学……改善治疗”
- 批准号:
9330483 - 财政年份:2016
- 资助金额:
$ 63.76万 - 项目类别:
Raman Molecular Imaging for Early Detection of Colon Cancer
拉曼分子成像用于结肠癌的早期检测
- 批准号:
8819022 - 财政年份:2015
- 资助金额:
$ 63.76万 - 项目类别:
Raman Molecular Imaging for Early Detection of Colon Cancer
拉曼分子成像用于结肠癌的早期检测
- 批准号:
9678998 - 财政年份:2015
- 资助金额:
$ 63.76万 - 项目类别:
(PQC2)High-content Pathology with Confocal Microscope Arrays
(PQC2)使用共焦显微镜阵列进行高内涵病理学
- 批准号:
8722518 - 财政年份:2013
- 资助金额:
$ 63.76万 - 项目类别:
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
乳腺癌微环境中EMT的动态成像
- 批准号:
8577999 - 财政年份:2013
- 资助金额:
$ 63.76万 - 项目类别:
(PQC2)High-content Pathology with Confocal Microscope Arrays
(PQC2)使用共焦显微镜阵列进行高内涵病理学
- 批准号:
8884395 - 财政年份:2013
- 资助金额:
$ 63.76万 - 项目类别:
(PQC2)High-content Pathology with Confocal Microscope Arrays
(PQC2)使用共焦显微镜阵列进行高内涵病理学
- 批准号:
8591233 - 财政年份:2013
- 资助金额:
$ 63.76万 - 项目类别:
Dynamic Imaging for EMT in Breast Cancer Microenvironment
乳腺癌微环境中 EMT 的动态成像
- 批准号:
9690370 - 财政年份:2013
- 资助金额:
$ 63.76万 - 项目类别:
Image-Guided Resection to Improve Outcome for Children with Medulloblastoma
图像引导切除术可改善髓母细胞瘤儿童的预后
- 批准号:
7990876 - 财政年份:2010
- 资助金额:
$ 63.76万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Operating Grants
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 63.76万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 63.76万 - 项目类别:
Research Grants














{{item.name}}会员




